JAIME GRIFFITH: Open Payments
NPI 1235790361 · CUSHING, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$538 in 24 payments from 15 companies in 2025. Trend: 2023 $570 · 2024 $407 · 2025 $538
Food & beverage: $538
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $117 |
| Viatris Specialty LLC | 4 | $77 |
| ABBVIE INC. | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Novo Nordisk Inc | 2 | $32 |
| Amgen Inc. | 2 | $31 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Boston Scientific Corporation | 1 | $20 |
Products named: Symbravo, YUPELRI, BREZTRI, TRELEGY ELLIPTA, INSPIRE, UBRELVY, LINZESS, Kerendia.
Industry payments across OK — which companies pay providers there.
